ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1



Keynote Address 2

Session Chair(s)

Kihito  Takahashi

Kihito Takahashi

Head of R&D/Medical Affairs Hub Japan

Swedish Orphan Biovitrium (SOBI) Japan, Japan

For realization of genomic medicine, we need to elucidate characteristics, temporal-spatial diversity and origin of cancer by using large-scale sequencing data analyses obtained from whole genome sequence, RNA sequence, and methylation sequence. The Institute of Medical Science, The University of Tokyo, aims to establish the integrated computational life science that constitutes the basis for personalized/preventive medicine. This requires a methodology for comprehensive understanding of pathological states and exploration of their effective treatments through a view from genome to the whole body, both environmentand organism-spatiotemporally. We consider that this methodology can be realized by “information technology”, “application of physics principles”, and “utilization of big data”. In this keynote lecture, the perspective on the genomic medicine and the innovation strategy for drug development will be described, from the viewpoints of the integrated computational life science.


Satoru  Miyano, PhD

Perspective on the Genomic Medicine Based on the Integrated Computational Life Science

Satoru Miyano, PhD

The University of Tokyo, Japan

Professor, Human Genome Center, The Institute of Medical Science